KBC Group’s Cellectis CLLS Stock Holding History

KBC Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-163,447	Closed	-$347K	–	1840
2024 Q3	$347K	Hold	163,447	–	–	﹤0.01%	761
2024 Q2	$306K	Hold	163,447	–	–	﹤0.01%	767
2024 Q1	$433K	Hold	163,447	–	–	﹤0.01%	738
2023 Q4	$503K	Hold	163,447	–	–	﹤0.01%	744
2023 Q3	$258K	Hold	163,447	–	–	﹤0.01%	799
2023 Q2	$322K	Hold	163,447	–	–	﹤0.01%	816
2023 Q1	$315K	Hold	163,447	–	–	﹤0.01%	848
2022 Q4	$343K	Hold	163,447	–	–	﹤0.01%	824
2022 Q3	$374K	Hold	163,447	–	–	﹤0.01%	813
2022 Q2	$463K	Hold	163,447	–	–	﹤0.01%	775
2022 Q1	$742K	Hold	163,447	–	–	﹤0.01%	733
2021 Q4	$1.33M	Hold	163,447	–	–	﹤0.01%	670
2021 Q3	$2.06M	Sell	163,447 -89,723	-35%	-$1.24M	0.01%	658
2021 Q2	$3.92M	Buy	253,170 +91,334	+56%	+$1.54M	0.01%	670
2021 Q1	$3.27M	Buy	161,836 +6,374	+4%	+$158K	0.01%	684
2020 Q4	$23.1M	Buy	155,462 +59,298	+62%	+$1.33M	0.01%	632
2020 Q3	$1.78M	Buy	96,164 +29,138	+43%	+$517K	0.01%	728
2020 Q2	$1.19M	Buy	67,026 +48,405	+260%	+$737K	﹤0.01%	786
2020 Q1	$171K	Hold	18,621	–	–	﹤0.01%	1061
2019 Q4	$319K	Hold	18,621	–	–	﹤0.01%	1216
2019 Q3	$194K	Hold	18,621	–	–	﹤0.01%	1259
2019 Q2	$290K	Hold	18,621	–	–	﹤0.01%	1175
2019 Q1	$342K	Buy	18,621 +4,355	+31%	+$77.2K	﹤0.01%	1164
2018 Q4	$238K	Buy	14,266 +2,661	+23%	+$61.7K	﹤0.01%	1099
2018 Q3	$327K	Hold	11,605	–	–	﹤0.01%	1213
2018 Q2	$328K	Hold	11,605	–	–	﹤0.01%	1082
2018 Q1	$366K	Sell	11,605 -1,244	-10%	-$39.3K	﹤0.01%	1022
2017 Q4	$375K	Hold	12,849	–	–	﹤0.01%	1025
2017 Q3	$366K	Buy	+12,849	New	+$332K	﹤0.01%	1025

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KBC Group's CLLS Position: Q4 2024 in Review

KBC Group sold out of Cellectis (CLLS) in Q4 2024, closing a stake of 163,447 shares — an estimated $347K sold.

KBC Group first reported a position in CLLS in Q3 2017 and held it in 29 quarters. The position peaked at $23.1M in Q4 2020. 29 funds tracked by Wall St. Rank hold CLLS as of Q4 2024.

KBC Group reported no remaining Cellectis position as of Q4 2024 after selling out during the quarter.
KBC Group sold 163,447 Cellectis shares in Q4 2024, an estimated $347K.
KBC Group first reported a position in Cellectis in Q3 2017 and held it in 29 quarters.
KBC Group's Cellectis position peaked at $23.1M in Q4 2020.
29 funds tracked by Wall St. Rank held Cellectis as of Q4 2024.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.